EV/EBITDA:
-8.97-0.15(-1.70%)Summary
- As of today (June 28, 2025), CRSP EV/EBITDA is -8.97, with a fall of -0.15 (-1.70%) during the most recent trading session on June 27, 2025.
- Over the past year, CRSP EV/EBITDA has increased by +6.23 (+40.99%).
- CRSP EV/EBITDA is now -100.42% below its all-time high of 2149.62.
Performance
CRSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRSP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.7% | +1.7% | +1.7% |
| 1 m1 month | -26.5% | +26.5% | +26.4% |
| 3 m3 months | - | - | +24.8% |
| 6 m6 months | +18.2% | +19.0% | +18.7% |
| ytdytd | -21.7% | +23.9% | +20.7% |
| 1 y1 year | +41.0% | -3.6% | -14.3% |
| 5 y5 years | -106.6% | +9.0% | -35.9% |
CRSP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.85 | -30.9% | -9.01 | +0.4% |
| 3 m | 3-month | -6.26 | -43.3% | -9.01 | +0.4% |
| 6 m | 6-month | -6.26 | -43.3% | -10.97 | +18.2% |
| 1 y | 1-year | -6.26 | -43.3% | -15.28 | +41.3% |
| 3 y | 3-year | 14.21 | -163.1% | -36.33 | +75.3% |
| 5 y | 5-year | 2149.62 | -100.4% | -49.83 | +82.0% |
| alltime | all time | 2149.62 | -100.4% | -732.31 | +98.8% |
CRSP EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -8.97(+21.7%) |
| 2024 | -7.37(-69.4%) |
| 2023 | -24.05(+371.6%) |
| 2022 | -5.10(-138.9%) |
| 2021 | 13.12(-144.4%) |
| Date | Value |
|---|---|
| 2020 | -29.57(-154.1%) |
| 2019 | 54.62(-928.8%) |
| 2018 | -6.59(-43.1%) |
| 2017 | -11.58(-67.5%) |
| 2016 | -35.60 |
FAQ
- What is CRISPR Therapeutics AG EV/EBITDA?
- What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
- What is CRSP EV/EBITDA year-to-date change?
- What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
What is CRISPR Therapeutics AG EV/EBITDA?
The current EV/EBITDA of CRSP is -8.97
What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high EV/EBITDA is 2149.62
What is CRSP EV/EBITDA year-to-date change?
CRISPR Therapeutics AG EV/EBITDA has changed by -1.60 (-21.71%) since the beginning of the year
What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
Over the past year, CRSP EV/EBITDA has changed by +6.23 (+40.99%)